Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph Pantophlet

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Journal of Virology|May 25, 2007
Susceptibility of recently transmitted subtype B human immunodeficiency virus type 1 variants to broadly neutralizing antibodiesEsther D Quakkelaar, Floris P J van Alphen, Brigitte D M Boeser-Nunnink, et al.
Journal of Virology|June 24, 2011
Binding of the mannose-specific lectin, griffithsin, to HIV-1 gp120 exposes the CD4-binding siteKabamba Bankoledi Alexandre, Elin S Gray, Ralph Pantophlet, et al.
Science (New York, N.Y.)|March 5, 2026
A unified platform for nucleoside analog synthesisMatthew J Anketell, Ethan Fung, Wenbin Liu, et al.
Plos One|May 12, 2015
Identification of CD4-Binding Site Dependent Plasma Neutralizing Antibodies in an HIV-1 Infected Indian IndividualLubina Khan, Muzamil Ashraf Makhdoomi, Sanjeev Kumar, et al.
Journal of Virology|June 20, 2002
The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120Christopher N Scanlan, Ralph Pantophlet, Mark R Wormald, et al.
Journal of Virology|December 11, 2012
2G12-expressing B cell lines may aid in HIV carbohydrate vaccine design strategiesKatie J Doores, Michael Huber, Khoa M Le, et al.
Journal of Virology|April 25, 2008
A glycoconjugate antigen based on the recognition motif of a broadly neutralizing human immunodeficiency virus antibody, 2G12, is immunogenic but elicits antibodies unable to bind to the self glycans of gp120Rena D Astronomo, Hing-Ken Lee, Christopher N Scanlan, et al.
Advances in Experimental Medicine and Biology|January 13, 2004
The carbohydrate epitope of the neutralizing anti-HIV-1 antibody 2G12Christopher N Scanlan, Ralph Pantophlet, Mark R Wormald, et al.
Biochemistry|February 18, 2004
Mode of action for linear peptide inhibitors of HIV-1 gp120 interactionsAlyssa C Biorn, Simon Cocklin, Navid Madani, et al.
Journal of Virology|April 6, 2007
Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donorsAmandeep K Dhillon, Helen Donners, Ralph Pantophlet, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Journal of Virology|May 25, 2007
Susceptibility of recently transmitted subtype B human immunodeficiency virus type 1 variants to broadly neutralizing antibodiesEsther D Quakkelaar, Floris P J van Alphen, Brigitte D M Boeser-Nunnink, et al.
Journal of Virology|June 24, 2011
Binding of the mannose-specific lectin, griffithsin, to HIV-1 gp120 exposes the CD4-binding siteKabamba Bankoledi Alexandre, Elin S Gray, Ralph Pantophlet, et al.
Science (New York, N.Y.)|March 5, 2026
A unified platform for nucleoside analog synthesisMatthew J Anketell, Ethan Fung, Wenbin Liu, et al.
Plos One|May 12, 2015
Identification of CD4-Binding Site Dependent Plasma Neutralizing Antibodies in an HIV-1 Infected Indian IndividualLubina Khan, Muzamil Ashraf Makhdoomi, Sanjeev Kumar, et al.
Journal of Virology|June 20, 2002
The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120Christopher N Scanlan, Ralph Pantophlet, Mark R Wormald, et al.
Journal of Virology|December 11, 2012
2G12-expressing B cell lines may aid in HIV carbohydrate vaccine design strategiesKatie J Doores, Michael Huber, Khoa M Le, et al.
Journal of Virology|April 25, 2008
A glycoconjugate antigen based on the recognition motif of a broadly neutralizing human immunodeficiency virus antibody, 2G12, is immunogenic but elicits antibodies unable to bind to the self glycans of gp120Rena D Astronomo, Hing-Ken Lee, Christopher N Scanlan, et al.
Advances in Experimental Medicine and Biology|January 13, 2004
The carbohydrate epitope of the neutralizing anti-HIV-1 antibody 2G12Christopher N Scanlan, Ralph Pantophlet, Mark R Wormald, et al.
Biochemistry|February 18, 2004
Mode of action for linear peptide inhibitors of HIV-1 gp120 interactionsAlyssa C Biorn, Simon Cocklin, Navid Madani, et al.
Journal of Virology|April 6, 2007
Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donorsAmandeep K Dhillon, Helen Donners, Ralph Pantophlet, et al.
Pageof 6